What is the dosage and treatment plan for Nitazoxanide (Nizonide) for parasitic infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitazoxanide (Nizonide) Dosage and Treatment Plan for Parasitic Infections

For parasitic infections, nitazoxanide should be administered for 3 days, with dosing based on age: 100 mg twice daily for children 1-3 years, 200 mg twice daily for children 4-11 years, and 500 mg twice daily for individuals 12 years and older. 1, 2

Dosage Recommendations by Age Group

  • Children 1-3 years old: 100 mg (5 mL of suspension) twice daily for 3 days 1, 2
  • Children 4-11 years old: 200 mg (10 mL of suspension) twice daily for 3 days 1, 2
  • Adolescents ≥12 years and adults: 500 mg tablet twice daily for 3 days 2

Effectiveness for Specific Parasitic Infections

Giardia lamblia

  • Clinical response rates of 85-100% in adults and adolescents when administered for 3 days 2
  • In pediatric patients, clinical response rate of 85% (intent-to-treat analysis) and 90% (per protocol analysis) 2
  • Comparable efficacy to metronidazole but with shorter treatment duration (3 days vs. 5 days) 2, 3

Cryptosporidium

  • Effective in immunocompetent patients with response rates of 56-96% depending on age and immune status 1, 2
  • Less effective in HIV-infected patients with low CD4 counts (<50/μL) 1
  • Should be combined with effective antiretroviral therapy in HIV-infected patients 1

Other Parasites

  • Effective against Entamoeba histolytica with 94% clinical response rate 4
  • Has shown efficacy against Enterocytozoon bieneusi infection in HIV-infected adults 1
  • Effective against various helminths including Taenia saginata (beef tapeworm) with 98% cure rate 5

Administration Guidelines

  • Nitazoxanide should always be administered with food 2
  • For oral suspension: shake well before each administration 2
  • The reconstituted suspension may be stored at room temperature for up to 7 days 2

Treatment Considerations

  • Clinical response should be evaluated 4-7 days following the end of treatment 2
  • A "well" clinical response is defined as "no symptoms, no watery stools and no more than 2 soft stools with no hematochezia within the past 24 hours" or "no symptoms and no unformed stools within the past 48 hours" 2
  • Some patients with clinical improvement may still have parasites in stool samples after treatment; management should be based on clinical response 2

Supportive Care

  • Maintain adequate hydration and correct electrolyte abnormalities 1
  • Continue age-appropriate nutrition during treatment 1
  • Antimotility agents should be used with caution, especially in young children 1

Common Pitfalls and Caveats

  • Nitazoxanide may be less effective in severely immunocompromised patients, particularly those with AIDS and low CD4 counts 1, 2
  • For cryptosporidiosis in HIV-infected patients, immune reconstitution through antiretroviral therapy is crucial for clearance of infection 1
  • The drug is generally well-tolerated with minimal side effects (primarily mild abdominal pain) 6, 3
  • For treatment failures, consider alternative agents or extended treatment courses 1, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nitazoxanide in the treatment of amoebiasis.

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2007

Research

Successful treatment of niclosamide- and praziquantel-resistant beef tapeworm infection with nitazoxanide.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2008

Research

Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico.

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1997

Guideline

Giardiasis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.